Search Results - "CENGİZ SEVAL, Güldane"

Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis by Çubukçu, Hikmet Can, Mesutoğlu, Pınar Yurdakul, Seval, Güldane Cengiz, Beksaç, Meral

“…The present systematic review aimed to investigate natural killer (NK) cell ex vivo expansion protocols within the scope of clinical trials targeting…”
Get full text

A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT by Özkan, Elgin, Araz, Mine, Cengiz Seval, Güldane, Nak, Demet, Beksaç, Meral

“…A 51-year-old male with recurrent multiple myeloma (MM) was referred for positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated…”
Get full text

Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation by Cengiz Seval, Güldane, Topçuoğlu, Pervin, Demirer, Taner

“…Hematopoietic stem cell transplantation is an established treatment for patients with a wide range of malignant and nonmalignant conditions. Noninfectious…”
Get full text

The Many Faces of Multiple Myeloma by Bol, Asya Tuğçe, Cengiz Seval, Güldane, Beksaç, Meral, Kuzu, Işınsı

Get full text

Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data by Kırcalı, Ekin, Cengiz Seval, Güldane, Öztürk, Cemaleddin, Yılmaz, Hülya, Koyun, Derya, Civriz Bozdağ, Sinem, Toprak, Selami Koçak, Topçuoğlu, Pervin, Arslan, Önder, Özcan, Muhit, Demirer, Taner, İlhan, Osman, Gürman, Günhan, Beksaç, Meral, Kurt Yüksel, Meltem

“…Eltrombopag has an off-label indication for haematopoietic cell transplantation in patients experiencing delayed thrombocyte recovery and/or thrombocytopaenia…”
Get full text

Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience by Yılmaz, Fergün, Soyer, Nur, Cengiz Seval, Güldane, Civriz Bozdağ, Sinem, Topcuoğlu, Pervin, Ünal, Ali, Kaynar, Leylagül, Özgür, Gökhan, Sucak, Gülsan, Göker, Hakan, Velet, Mustafa, Özdoğu, Hakan, Yılmaz, Mehmet, Kaya, Emin, Salim, Ozan, Deveci, Burak, Karadoğan, İhsan, Saydam, Güray, Şahin, Fahri, Vural, Filiz

“…Although inhibition of the complement system at different steps is a promising therapy modality in patients with paroxysmal nocturnal hemoglobinuria (PNH),…”
Get full text

Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors by Narlı Özdemir, Zehra, Şahin, Uğur, Dalva, Klara, Baltacı, Mehmet Akif, Uslu, Atilla, Öztürk, Cemaleddin, Cengiz Seval, Güldane, Toprak, Selami Koçak, Kurt Yüksel, Meltem, Topçuoğlu, Pervin, Arslan, Önder, Özcan, Muhit, Beksaç, Meral, İlhan, Osman, Gürman, Günhan, Civriz Bozdağ, Sinem

“…Objective: The optimal timing of measurable residual disease (MRD) evaluation in acute myeloid leukemia (AML) patients has not been well defined yet. We aimed…”
Get full text

First Experience of 11C-Methionine PET in Multiple Myeloma in Turkey by Özkan, Elgin, Cengiz Seval, Güldane, Araz, Mine, Küçük, Nuriye Özlem, Beksaç, Meral

Get full text

Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease by Koyun, Derya, Seval, Güldane Cengiz, Kırcalı, Ekin, Bozdağ, Sinem Civriz, Toprak, Selami Koçak, Topçuoğlu, Pervin, Özcan, Muhit, Arslan, Önder, Demirer, Taner, İlhan, Osman, Beksaç, Meral, Gürman, Günhan, Yüksel, Meltem Kurt

“…Steroid-refractory acute graft-versus-host disease (SR-aGVHD) treatment has a low response rate and a high risk of infection in allogeneic hematopoietic stem…”
Get full text

Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model by Cengiz Seval, Güldane, Özkavukçu, Sinan, Seval, Murat, Aylı, Meltem

“…Tyrosine kinase inhibitors may have deleterious effects on spermatogenesis or folliculogenesis, resulting in male or female subfertility. The aim of this study…”
Get full text

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report by Aylı, Meltem, Özcan, Muhit, Cengiz Seval, Güldane

“…A 67-year-old male patient who was diagnosed with primary myelofibrosis 4 years ago did not respond to conventional therapies. The splenomegaly progressively…”
Get full text

Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series by Sönmezer, Murat, Şükür, Yavuz Emre, Saçıntı, Koray Görkem, Özkavukçu, Sinan, Kankaya, Duygu, Atabekoğlu, Cem Somer, Cengiz Seval, Güldane, Oktay, Kutluk H

“…With increased success, ovarian tissue cryopreservation has recently become a standard technique for fertility preservation. However, malignant cell…”
Get full text

Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review by Uslu, Atilla, Seval, Güldane Cengiz, Merter, Mustafa, Dalva, Klara, Beksaç, Meral

“…•Daratumumab Carfilzomib may induce deep response as manifested by serial flow cytometric evaluations of the pleural myeloma infiltration…”
Get full text

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG) by Kastritis, Efstathios, Katodritou, Eirini, Badelita, Sorina, Bila, Jelena, Seval, Güldane Cengiz, Cvetkovic, Zorica, Coriu, Daniel, Spanoudakis, Emmanouil, Dalampira, Dimitra, Sretenovic, Aleksandra, Sevastoudi, Aggeliki, Bojan, Anca, Mitrovic, Marko, Danaila, Catalin, Gavriatopoulou, Maria, Roussou, Maria, Charalampous, Charalampos, Terpos, Evangelos, Beksac, Meral, Dimopoulos, Meletios A

Get full text

Evaluation of the Efficacy and Safety Immunosuppressive Therapy in Patients with Acquired Factor VIII and IX Inhibitor by Koyun, Derya, Cengiz Seval, Güldane, Civriz Bozdağ, Sinem, Özcan, Muhit, Topçuoğlu, Pervin

“…Objectives: Acquired factor inhibitor is a rare disorder and can cause life-threatening bleeding. Consequently, we report the efficacy and safety of our…”
Get full text

Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic by Seval, Güldane Cengiz, Topçuoğlu, Pervin, Demirer, Taner

“…The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making…”
Get full text

PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR by Koyun, Derya, Seval, Güldane Cengiz, Civrizbozdağ, Sinem, Özcan, Muhit, Topçuoğlu, Pervin

Get full text

A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity by Beksac, Meral, Akin, Hasan Yalim, Gencer-Oncul, Emine Begum, Yousefzadeh, Mahsa, Cengiz Seval, Guldane, Gulten, Ezgi, Akdemir Kalkan, Irem, Cinar, Gule, Memikoglu, Osman, Karaagaoglu, Ergun, Dalva, Klara

“…Associations between inherited Killer Immunoglobulin-like Receptor (KIR) genotypes and the severity of multiple RNA virus infections have been reported. This…”
Get full text

First Experience of 11C-Methionine PET in Multiple Myeloma in Turkey by Özkan, Elgin, Güldane, Cengiz Seval, Araz, Mine, Nuriye Özlem Küçük, Beksaç, Meral

Get full text

Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation by Atilla, Erden, Ataca Atilla, Pınar, Cengiz Seval, Güldane, Bektaş, Mehmet, Demirer, Taner

“…The gastrointestinal (GI) system is one of the most commonly affected sites during a hematopoietic stem cell transplantation (HSCT) due to toxicities of…”
Get full text